StockData
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO) stock

ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$0.81+0.01 (+1.06%)

Close on Nov 17, 2026Market cap $104.43MP/E –Yield –

Organogenesis EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Organogenesis's EV/EBITDA was 11.5× on Jul 31, 2026, against 276.5× a year earlier. Over the last 5 years it ranged from 3.4× to 327.8×, with a median of 14.9×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 202611.5×−80.5
2025Dec 31, 202592.0×−184.5
2024Oct 31, 2024276.5×+257.0
2023Dec 29, 202319.5×+12.1
2022Dec 30, 20227.3×−7.3
2021Dec 31, 202114.7×−218.2
2020Dec 31, 2020232.9×–

More Organogenesis figures

See a number that looks wrong?